| Sep 14 |
Celldex Therapeutics, Inc. (CLDX): Short Seller Sentiment is Bearish on This Cancer Stock
|
| Sep 12 |
Celldex Therapeutics to Present at Upcoming Investor Conferences
|
| Aug 12 |
7 Analysts Have This To Say About Celldex Therapeutics
|
| Aug 10 |
Celldex Therapeutics Second Quarter 2024 Earnings: Beats Expectations
|
| Aug 8 |
Celldex GAAP EPS of -$0.54 beats by $0.05, revenue of $2.49M beats by $1.64M
|
| Aug 8 |
Celldex Therapeutics (CLDX) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 8 |
Celldex: Q2 Earnings Snapshot
|
| Aug 8 |
Celldex Reports Second Quarter 2024 Financial Results and Provides Corporate Update
|
| Jul 31 |
Celldex: Latest Urticaria Data Gives Market Jitters - I'm On Sidelines
|
| Jul 30 |
Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
|
